Download by
Scanning QR Code
No Stock Yet
Can Maider Medical Industry Equipment Co. Ltd.'s (SHSE:688310) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?
Maider Medical Industry Equipment's (SHSE:688310) stock is up by a considerable 65% over the past three months. However, in this article, we decided to focus on its weak fundamentals, as long-term f
Medtech Healthcare: Currently, contact lens-related business has not generated sales revenue
Changes in the sector | China's medical device market rose to second place in the world, and the medical device sector fluctuated higher
The Zhitong Finance App learned that on March 6, the A-share medical device sector fluctuated higher due to news that China's medical device market will continue to have a ten-year golden development period in the future. As of press release, Runda Medical (603108.SH) has risen and stopped, and Microelectrophysiology (688351.SH), Maide Medical (), Delray Medical (300396.SZ), Kangzhong Medical (), Jiuqiang Biology (300406.SZ), Tianzhihang () and other stocks have risen. 688310.SH 688607.SH 688277.SH Roland Berger recently published “Development of China's Medical Device Industry
The ophthalmology treatment sector declined in early trading, with Xingqi Eye Medicine falling more than 10%, Dr. Glasses falling more than 8%, and Maitai Medical, Huaxia Ophthalmology, and Mingyue Lenses followed suit.
Maider Medical Industry Equipment's (SHSE:688310) One-year Earnings Growth Trails the Respectable Shareholder Returns
If you want to compound wealth in the stock market, you can do so by buying an index fund. But one can do better than that by picking better than average stocks (as part of a diversified portfolio).
Medtech Healthcare (688310.SH)'s net profit of 65.24 million yuan in 2022 increased 1.18% year-on-year
According to the Zhitong Finance App, Medtech Healthcare (688310.SH) disclosed its 2022 annual performance report. The company achieved total annual revenue of 384 million yuan, an increase of 21.76% over the previous year. Net profit attributable to owners of the parent company was 65.2396 million yuan, an increase of 1.18% over the previous year. Net profit attributable to parent company owners after deducting non-recurring profit and loss was 56.9084 million yuan, a year-on-year decrease of 1.89%. Basic earnings per share were $0.78 per share. During the reporting period, the increase in the company's net profit was low, mainly due to increases in share payment fees, etc. Payment fees for company shares during the reporting period
Medtech Healthcare Performance Report: 2022 net profit increased 1.18% year-on-year
Maider Medical Industry Equipment Co. Ltd.'s (SHSE:688310) Chairman of Management Board Junhua Li Is the Most Upbeat Insider, and Their Holdings Increased by 17% Last Week
Every investor in Maider Medical Industry Equipment Co. Ltd. (SHSE:688310) should be aware of the most powerful shareholder groups. With 63% stake, individual insiders possess the maximum shares in t
Maide Healthcare (688310.SH): “Medical Consumables Intelligent Equipment Construction Project” and “Technology Center Construction Project” completed
Glonghui, January 16, 丨 Medtech Healthcare (688310.SH) announced that on January 15, 2023, the company held the 8th meeting of the fourth board of directors and the 8th meeting of the fourth board of supervisors to review and pass the “Proposal on the Settlement of Initial Public Offering of Stock Fundraising Projects and Permanently Supplementing Liquidity with Savings Funds”, agreeing that the company would close the initial public stock raising project “Medical Consumables Intelligent Equipment Construction Project” and use the savings raised (in addition to the overraised capital) to permanently supplement the company's working capital. This matter is within the authority of the board of directors to approve, and there is no need to mention it
Medtech Healthcare (688310.SH) received a total of 9955,500 yuan in government grants
Glonghui, November 28, 丨 Medtech Healthcare (688310.SH) announced that from July 12, 2022 to the disclosure date of the announcement, the company and its holding subsidiaries received a total of about RMB 9.9555 million in government subsidies, including revenue-related government subsidies of RMB 7.6055 million and asset-related government subsidies of RMB 2.35 million.
Loading...
No Stock Yet